Portugal (PT)

PICOSEC-Micromegas Detector, an innovative solution for Lepton Time Tagging (2024) Kallitsopoulou A, Aleksan R, Angelis Y, Aune S, Bortfeldt J, Brunbauer F, Brunoldi M, et al. Journal article Understanding the risk of ionizing radiation in breast imaging: Concepts and quantities, clinical importance, and future directions (2024) Di Maria S, van Nijnatten TJ, Jeukens CR, Vedantham S, Dietzel M, Vaz P Journal article Publisher Correction: Determinants of exposure to acrylamide in European children and adults based on urinary biomarkers: results from the “European Human Biomonitoring Initiative” HBM4EU participating studies (Scientific Reports, (2023), 13, 1, (21291), 10.1038/s41598-023-48738-6) (2024) F. Fernández S, Poteser M, Govarts E, Pardo O, Coscollà C, Schettgen T, Vogel N, et al. Journal article, Erratum METhodological RadiomICs Score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII (2024) Kocak B, Akinci D’Antonoli T, Mercaldo N, Alberich-Bayarri A, Baessler B, Ambrosini I, Andreychenko AE, et al. Journal article Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer (2024) Schmid P, Cortes J, Dent R, Mcarthur H, Pusztai L, Kümmel S, Denkert C, et al. Journal article Sclerosing mucoepidermoid carcinoma of salivary glands (2024) Othman BK, Bradová M, Simpson RH, Laco J, Agaimy A, Rito M, Ihrler S, et al. Journal article 3D printed photopolymer derived carbon catalysts for enhanced wet peroxide oxidation (2024) Silva AS, Diaz de Tuesta JL, Henrique A, Roman FF, Omralinov D, Steldinger H, Gläsel J, et al. Journal article EANS Epilepsy surgery Brain Dissection Course Vienna 2024 (2024) Rössler K, Van Roost D, Schijns O, Ackermans L, Delev D, Batista PD, Erőss L, et al. Journal article ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment (2024) Adamina M, Minozzi S, Warusavitarne J, Buskens CJ, Chaparro M, Verstockt B, Kopylov U, et al. Journal article Neoadjuvant pembrolizumab plus chemotherapy/adjuvant pembrolizumab for early-stage triple-negative breast cancer: Quality-of-life results from the randomized KEYNOTE-522 study (2024) Dent R, Cortés J, Pusztai L, McArthur H, Kümmel S, Bergh J, Denkert C, et al. Journal article